Clinical trial
Prevention of Contrast Nephropathy by Sodium Bicarbonate Versus Sodium Chloride…
NCT00353340 · Shaare Zedek Medical Center, Other · Completed
Key facts
| NCT number | NCT00353340 |
|---|---|
| Title | Prevention of Contrast Nephropathy by Sodium Bicarbonate Versus Sodium Chloride and N-acetylcysteine |
| Official title | Prevention of Contrast Nephropathy by Sodium Bicarbonate Versus Sodium Chloride and N-acetylcysteine in Patients Undergoing Cardiac Catheterization |
| Lead sponsor | Shaare Zedek Medical Center, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Acute Renal Failure Contrast Nephropathy |
| Intervention type | Drug |
| Interventions | n acetylcysteine, sodium bicarbonate, sodium chloride |
| Enrollment | 250 |
| Start date | Jan 1, 2005 |
| Primary completion | Jan 1, 2008 |
| Completion | May 1, 2009 |
| First posted | Jul 18, 2006 |
| Last update posted | Feb 25, 2010 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: